Emerald Health Therapeutics’ Joint Venture Achieves Its Full Annualized Production Run-Rate VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc.’s (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) 50%-owned joint venture for large-scale, low-cost,...

Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse is Fully Planted; Reporting Year End Financials May 1st Pure Sunfarms on track to reach annual production run-rate of 75,000 kilograms by mid-2019 Company to host 2018 fourth quarter and year end financial results conference call Wednesday, May 1, 2019 at...